CREBBP loss drives immune evasion by epigenetically silencing STING and MHC-I in small cell lung cancer
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
Here, we identify CREBBP loss, a frequent genetic alteration in SCLC, as a key suppressor of tumor cell-intrinsic immune responses that drives an immune-cold tumor microenvironment in Rb1/Trp53 -driven autochthonous mouse models.
Appeared: Friday, October 23. Science Advances. Peer-reviewed journal.